CD8A and Crohn disease: As shown in Fig. 7c and Supplementary Figs 11b,12, A2A receptor signalling following use of adenosine or/and more specific agonists, for example, CGS21680, decreased IFNγ production of both blood and lamina propria CD8+ T cells from Crohn's disease patients in vitro.